Machado Patrick
SEC-identified person · CIK 1311210 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Arcus Biosciences, Inc. RCUS | Director | filed 2019 - 2026 |
| Xenon Pharmaceuticals Inc. XENE | Director | filed 2020 - 2026 |
| Avalanche Biotechnologies, Inc. [AAVL] | Director | filed 2017 - 2025 |
| Alumis INC. NASDAQ | Director | filed 2024 - 2025 |
| Acelyrin, Inc. SLRN | Director | filed 2023 - 2025 |
| Turnstone Biologics Corp. TSBX | Director | filed 2023 - 2023 |
| Chimerix INC CRMX | Director | filed 2014 - 2023 |
| Turning Point Therapeutics, Inc. TPTX | Director | filed 2019 - 2022 |
| Roivant Sciences Ltd. ROIV | Director | filed 2021 - 2021 |
| Principia Biopharma Inc. PRNB | Director | filed 2019 - 2020 |
| Tekmira Pharmaceuticals Corp TKMR | Officer | filed 2016 - 2019 |
| Sio Gene Therapies Inc. SIOX | Director | filed 2016 - 2019 |
| Myovant Sciences Ltd. MYOV | Officer | filed 2016 - 2019 |
| Urovant Sciences Ltd. UROV | Officer | filed 2018 - 2019 |
| Scynexis INC SCYX | Director | filed 2015 - 2019 |
| Endocyte INC ECYT | Director | filed 2018 - 2018 |
| Rocket Pharmaceuticals, INC. RCKT | Director | filed 2016 - 2017 |
| Medivation, INC. MDVN.OB | Director · Sr. Vice President and CFO | filed 2006 - 2016 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.